LAA Closure: Patient Selection & Clinical Indications in the Post-Approval Era

Loading...

By: David R. Holmes

More articles by this author

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Use of DCB in Coronary Territory: Position Document of the Academic Research Consortium

The use of drug-coated balloons (DCB) is emerging as one of the most promising strategies in coronary angioplasty, particularly in clinical scenarios where avoiding...

IVUS Guided PCI: New Expansion Threshold

Intravascular ultrasound (IVUS) guided percutaneous coronary intervention (PCI) has been shown to improve clinical outcomes vs the conventional angiography guided PCI. This benefit has...

Use of Drug-Coated Balloons in Chronic Total Occlusions: The ERCTO Registry

Chronic total coronary occlusions (CTO) are still a major challenge in interventional cardiology, affecting 16%–18% of patients with coronary artery disease. While drug-eluting stents...